Medical News

RSS

NIU seeks approval for new proton cancer treatment and research center

Northern Illinois University has named Northwestern Medical Faculty Foundation as its expected provider of clinical services for a new $160 million proton therapy cancer treatment and research center to be built in the DuPage National Technology Park about 35 miles west of Chicago.

27 Feb 2008

New insight into the fundamentals of Parkinson's disease

A single change in a protein may play a role in whether someone develops Parkinson's disease, say University of Florida Genetics Institute researchers writing in a recent issue of the Proceedings of the National Academy of Sciences.

27 Feb 2008

U of C research examines Botulinium type-A toxin

New Research at the University of Calgary, Faculty of Kinesiology suggests that Botulinium type-A toxin (BTX-A) passes easily to surrounding muscles and is more difficult to control once injected than many people suspect.

27 Feb 2008

Anti-tuberculosis drug resistance in the world

Multidrug-resistant tuberculosis (MDR-TB) has been recorded at the highest rates ever, according to a new report published today.

27 Feb 2008

New radiation therapy standards needed

Modern radiation techniques result in substantial variation between the prescribed dose and the actual dose of radiation delivered to the tumor, according to a study published online February 26 in the Journal of the National Cancer Institute.

27 Feb 2008

Neurofeedback (EEG biofeedback) may help those with autism

Research on autistic spectrum disorder (ASD) shows that neurofeedback (EEG biofeedback) can remediate anomalies in brain activation, leading to symptom reduction and functional improvement.

27 Feb 2008

NCMHD announces HIV/AIDS expert as new senior policy advisor

Idalia Ramos Sanchez, a longtime fighter for health equity especially as it relates to HIV/AIDS, has been appointed senior policy advisor at the National Center on Minority Health and Health Disparities (NCMHD), National Institutes of Health (NIH).

27 Feb 2008

New Alzheimer's patent by Affiris

Affiris GmbH has secured another Europe-wide patent for an innovative method of treating Alzheimer's disease. This new blood-cleansing method is similar to dialysis and is designed to reduce the amount of harmful protein deposits in the brain. It is based on the AFFITOME technology established by Affiris, which was patented in October 2007 for an Alzheimer's vaccine.

27 Feb 2008

Nasal vaccine for smallpox protects animals against 77 times the potentially lethal dose of smallpox

Scientists at NanoBio Corporation and the University of Michigan have demonstrated their nasally delivered vaccinia vaccine can protect animals against 77 times the potentially lethal dose of smallpox, and without the safety risks of current vaccines for smallpox.

27 Feb 2008

Nanoemulsion vaccines show increasing promise

A novel technique for vaccinating against a variety of infectious diseases - using an oil-based emulsion placed in the nose, rather than needles - has proved able to produce a strong immune response against smallpox and HIV in two new studies.

27 Feb 2008

Minimally invasive fibroid treatment fares well in multicenter trial

A new multicenter trial found that uterine artery embolization (UAE) is a good alternative to hysterectomy in women with symptomatic fibroids.

27 Feb 2008

Encyclopedia of Life

The first 30,000 pages of a massive online Encyclopedia of Life (EOL) were unveiled as scientists assemble for the prestigious Technology, Entertainment and Design (TED) Conference in Monterey, California.

27 Feb 2008

IRIS International completes study of 85 post-prostatectomy patients using investigational NADiA PSA assay

IRIS International Inc. has announced that its Iris Molecular Diagnostics (IMD) group has successfully completed a retrospective study of stored leftover serum of 85 post-prostatectomy patients, men who had their prostate removed due to prostate cancer, using its investigational NADiA (Nucleic Acid Detection ImmunoAssay) PSA Assay.

27 Feb 2008

Heart attack rates drop following national smoking bans in France

French researchers announced a striking 15% decrease in admissions of patients with myocardial infarction to emergency wards since the public ban on smoking came into effect in restaurants, hotels and casinos in France last January.

27 Feb 2008

Galderma to acquire CollaGenex Pharmaceuticals

Galderma Pharma S.A., a global specialty pharmaceutical company focused on dermatology, and CollaGenex Pharmaceuticals, Inc. has announced a definitive agreement pursuant to which Galderma's U.S. holding company, Galderma Laboratories, Inc., will acquire all of the outstanding shares of CollaGenex at a price of $16.60 per share in cash, representing approximately $420 million for the equity of CollaGenex.

27 Feb 2008

Advances in understanding human taste perception

Despite the significance of taste to both human gratification and survival, a basic understanding of this primal sense is still unfolding.

27 Feb 2008

First spatial map of global malaria risk

About 35 percent of the world's population is at risk of contracting deadly malaria, but many people are at a lower risk than previously thought, raising hope that the disease could be seriously reduced or eliminated in parts of the world.

27 Feb 2008

Faster chemo technique increases survival in children with neuroblastoma

Chemotherapy given with shorter intervals between treatments than conventional chemotherapy increases survival rates by two thirds in children with high-risk neuroblastoma , according to a study published in the Lancet Oncology * today (Tuesday).

27 Feb 2008

Facial asymmetry persists despite surgery to correct congenital deformity

Adults and teens that underwent surgery as infants to correct a congenital condition that causes the forehead and face to appear uneven still have a degree of facial asymmetry years later, according to new research led by a Hasbro Children's Hospital surgeon.

27 Feb 2008